Overview

Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease

Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
A phase I trial to study the safety of mobilization of stem cells with G-CSF and Mozobil in patients with chronic liver disease.
Phase:
Phase 1
Details
Lead Sponsor:
Proteonomix, Inc.
Collaborators:
Numoda
University of Medicine and Dentistry of New Jersey
Treatments:
JM 3100
Lenograstim
Plerixafor